Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma

BJU International

Volumn 111, Issue 4, 2013, Pages 589-595

  Ehdaie, Behfar ^a,b   Furberg, Helena ^b   Zabor, Emily Craig ^b   Ostroff, Jamie S ^b   Shariat, Shahrokh F ^c   Bochner, Bernard H ^a   Coleman, Jonathan A ^a   Dalbagni, Guido ^a  

^a Sidney Kimmel Center for Prostate and Urologic Cancers   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

nephrectomy; outcome assessment; prognosis; smoking; tobacco; urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METASTASIS; MULTIVARIATE ANALYSIS; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; TRANSITIONAL CELL CARCINOMA; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SURVIVAL ANALYSIS; URETER; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 84875860249     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11260.x     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233
3. Hartge P, Silverman D, Hoover R, et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 1987; 78: 1119-1125
4. Strope SA, Montie JE,. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 2008; 180: 31-37
5. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC,. Association between smoking and risk of bladder cancer among men and women. JAMA: the Journal of the American Medical Association 2011; 306: 737-745
6. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA., The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89: 630-639
7. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010; 42: 978-984
8. Scelo G, Brennan P,. The epidemiology of bladder and kidney cancer. Nature clinical practice. Urology 2007; 4: 205-217
9. Chen CS, Lee CH, Hsieh CD, et al. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res Treat 2011; 125: 73-87
10. Dasgupta P, Chellappan SP,. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 2006; 5: 2324-2328
11. Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 2009; 124: 36-45
12. Catassi A, Servent D, Paleari L, Cesario A, Russo P,. Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutation Research 2008; 659: 221-231
13. Mousa S, Mousa SA,. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. Journal of Cellular Biochemistry 2006; 97: 1370-1378
14. Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF,. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 2002; 90: 228-239
15. Chen CH, Shun CT, Huang KH, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 2007; 100: 281-286
16. Sfakianos J, Shariat SF, Favaretto RL, Rioja J, Herr HW,. Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder. BJU Int 2010; 108: 526-530
17. Simsir A, Sarsik B, Cureklibatir I, Sen S, Gunaydin G, Cal C,. Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status. Int Urol Nephrol 2011; 43: 1039-1045
18. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002
19. Epstein JI, Amin MB, Reuter VR, Mostofi FK,. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-1448
20. Gray R., A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154
21. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008; 53: 1217-1222
22. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E,. Smoking and prostate cancer survival and recurrence. JAMA: the Journal of the American Medical Association 2011; 305: 2548-2555
23. Joshu CE, Mondul AM, Meinhold CL, et al. Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst 2011; 103: 835-838
24. Benowitz NL, Schultz KE, Haller CA, Wu AH, Dains KM, Jacob P 3rd,. Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening. Am J Epidemiol 2009; 170: 885-891
25. McBride CM, Ostroff JS., Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control: Journal of the Moffitt Cancer Center 2003; 10: 325-333
26. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP,. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006; 106: 17-27
27. Dearing J., Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl 2005; 87: 85-87
28. Bjurlin MA, Goble SM, Hollowell CM,. Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol 2010; 184: 1901-1906
29. Curry SJ, Keller PA, Orleans CT, Fiore MC,. The role of health care systems in increased tobacco cessation. Annu Rev Public Health 2008; 29: 411-428
30. Tobacco cessation and quality cancer care. J Oncol Pract 2009; 5: 2-5